Pfiz­er, BioN­Tech de­ny Ar­bu­tus and Genevant’s Covid vac­cine patent in­fringe­ment claims

Pfiz­er and BioN­Tech re­spond­ed to a patent in­fringe­ment suit filed by Ar­bu­tus Bio­phar­ma and Genevant, deny­ing the ac­cu­sa­tion that their Covid-19 vac­cine in­fringed on patents …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER